Rab27a is a member of the Rab family of small GTPase protein, the first member of this protein family so far associated with a human disease, i.e. the Griscelli syndrome type 2.
Introduction
The Rab family of low-molecular-weight GTPase play an essential role in intracellular transport vesicles by controlling membrane trafficking between intracellular compartments.
Rab GTPases interact specifically with a subset of effector proteins, which, in turn could impart specificity to membrane trafficking at the levels of vesicle translocation, docking, and fusion [1] [2] [3] . In mammalian cells, over 50 Rab proteins have now been identified [4] [5] [6] . Rab27a is the only one, so far found associated with a human disease, i.e. the Griscelli syndrome. We previously reported that the Griscelli syndrome, characterized by a partial albinism of the skin and the hair and a severe immunological disorder, results from Rab27a deleterious mutations 7 .
Although Rab27a is wildly expressed, the clinical phenotype of the patients with Griscelli syndrome indicates a determinant role of this Rab protein in melanocytes and lymphocytes. In addition to its role in melanosome peripheral transfer, we have shown that Rab27a is required for cytotoxic granule exocytosis, and that the defective cytotoxic activity of patients' lymphocytes resulting from Rab27a mutation accounts for the severe immune disorder characteristic of this syndrome, known as hemophagocytic syndrome (HS) 7, 8 . HS is characterized by lymphoid organ and extranodal infiltration by polyclonal activated T cells, mostly of the CD8+ subset, and by activated macrophages that phagocytose blood cells. This condition does not, in most cases, spontaneously remit. Immune cell infiltration results in massive tissue necrosis, organ failure and death in the absence of immunosuppressive treatment. Massive cytokine release is another hallmark of the condition, and it is thought that macrophage activation is mostly the consequence of TNF production leading to hemophagocytosis, high triglyceride levels and coagulation disorders. Similarly, in the ashen mice, Rab27a mutation leads to defects in melanosome transport and granule exocytosis in cytotoxic T lymphocytes [9] [10] [11] . Recently, the product of the gene mutated in the leaden (Mlph  d ) mice 12 , the melanophilin (Mlph) (also known as Slac2-a), was identified as an effector of
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From Rab27a in melanocytes [12] [13] [14] [15] . The Mlph bridges Rab27a and the molecular motor myosin Va, this tripartite protein complex being required for melanosome transport function 16, 17 .
The molecular mechanisms, which underlie the diversity of Rab/effector interaction, are not yet fully understood. Rabs cycle between a GTP-bound, active, and a GDP-bound, inactive conformation, but this highly conserved mechanism among GTPase proteins, cannot account for the discrimination of diverse effectors and regulatory factors. In addition to Rab specific motifs present in all Rab GTPase, Rab subfamily-specific sequences (RabsF), with high amino acid conservation within subfamilies, have been identified and thought to participate to the specificity of regulator interaction 5 . 19 , was shown to exhibit a similar nucleotide binding site activity as compared to the constitutively active mutant Q78L but differs significantly in effector interaction and functional properties when overexpressed in cells. These data strongly support the physiological relevance of the invariant hydrophobic triad in effector recognition and suggest that the specific effectors of Rab27a in both melanocytes and lymphocytes require similar structural constraints for Rab27a interaction.
Patients
Three missense mutations (W73G, L130P and A152P) in the Rab27a gene were identified among 38 patients with Rab27a(-) Griscelli syndrome type 2 (GSB personal data). Mutations in three of these patients (P9, P15 and P17) have been previously reported 7, 20 . In a fourth patient (P37), the same homozygous T217G mutation leading to W73G transition as in P9 BamHI and subcloned into pcDNA 3.1; Pet15b/His; pFlag-CMV-4, and pEGFP-C1 vectors.
Molecular cloning of the SHD domain of human Mlph
A cDNA encoding the first 146 amino acid of human Mlph termed Slp homologie domain (SHD) 14 was synthesized from total RNA isolated from the human melanoma cell line, MNT-1 (gift of P.G. Natali, Instituto Regina Elena, Roma, Italia) by one step-RT-PCR with the following primers: 5'-GGAATTCATGGGGAAGAAACTGGAT-3' (EcoRI-MlphMet primer; sense) and 5'-CTCGAGCTGCATCCGCCCGTGGAGGGACCG -3'(XhoI-Mlph 146 primer; antisense). The digested PCR product was cloned in frame into pcDNA 3.1/MycHis, (Invitrogen), which adds the Myc epitope at the C terminus of the cloned cDNA.
Purification of recombinant proteins
E.coli BL21 cells were transformed with recombinant plasmid Pet15b containing the correct inserts and grown in the LB medium with 30µg /ml ampicilin. When A600 was 0,6, isopropyl-1-thio--D galactopyranoside was added to a final concentration of 1mM. Cells were harvested 3h later by centrifugation at 1500xg for 10min. Bacterial pellets were resuspended in 10mM Tris-HCl pH 8.8, 300mM NaCl, 1mM DTT, 10mM imidazol, 10µM
GTP, 10µg /ml PMSF and sonicated at 4°C. The lysate was centrifuged twice at 10000xg for 10 min. The mutants L130P and A152P were solubilized in 0,8% SDS, 250µM
Triethanolamine, 1,5% Sarcosyl and 0,5M EDTA. Purification was carried out according to the instruction manual of the QIAexpressionist TM (Qiagen S.A., Courtaboeuf, France).
Briefly, the supernatant was incubated with 300µl of Ni-NTA resin and mix gently for 2h at 4°C. The recombinant proteins were washed and eluted with 250mM imidazol. Before the binding assays, the proteins were dialyzed overnight against 20mM Tris-HCl pH 7.5, 1mM
DTT and 5mM MgCl 2 . The purity was estimated by SDS-PAGE, coomassie blue staining.
Protein concentration was determined by a Bradford assay (Pierce-Perbio Science, Bezons, France) using bovine serum albumin (Sigma) as a standard.
Binding of nucleotides
Recombinant proteins were incubated in 20mM Tris-HCl pH 7.5, 1mM DTT, 5mM
MgCl 2 , 10mM EDTA, 0,5g/l bovine serum albumin, ( 3 H)GTP or ( 3 H)GDP (7,7 Ci/mmol, Amersham-Pharmacia-Biotech, Saclay, France) and cold 30µM GTP or GDP. After incubation at 30°C for the indicated times, samples were diluted in 500µl of ice-cold washing buffer (20mM Tris-HCl pH 7.5, 25mM MgCl 2 and 100mM NaCl), applied to a nitrocellulose filter (0.45µm, millipore, Saint Quentin en Yvelines, France). The filters were rinsed with 4x 4ml ice-cold washing buffer and the radioactivity retained on the filters was determined by scintillation counting 24 .
GTPase activity
Proteins were preincubated for 1hour in the condition described above for nucleotide binding, with ( -32 P)GTP (5000 Ci/mmol, Amersham Pharmacia Biotech), then 20mM MgCl 2 to a final concentration was added. At the indicated times, samples were diluted with cold buffer, filtered and counted.
Cell culture, transient transfection and functional assay
The immortal control mouse melanocyte cell line, melan-a, was kindly provided by Mowiol anti-fading agent (Calbiochem, San Diego, CA). Cells were observed using an Axioplan 2 microscope (Zeiss, Jena, Germany). 293T cell line 25 were cultured in DMEM with 10% FCS at 37°C with 5% CO 2 and transfected by electroporation : 250V, 900µF
(EquiBio, UK). H. Saimiri-transformed CD8+ T cells 26 were kept continuously in medium containing IL2 (40U/ml). This T cell line was transiently transfected with various EGFPRab27a constructs using Human T cell Nucleofector Kit (Amaxa biosytem, Köln, Germany), and degranulation assay were tested 18h later using BLT esterase release analysis.
Intracellular expression of the various constructs was evaluated by FACScan analysis (Becton
Dickinson, San Diego, CA). Peripheral blood lymphocytes from patients or control were stimulated with PHA (1/700 dilution; Difco, Detroit, Michigan) for 24h, and then cultured in IL2 (40U/ml, Valbiotech) for 6 days. The degranulation assay was done on these cells as previously described 7 with some modifications. Briefly, anti-CD3 antibody (20µg/ml; OKT3, Ortoclone; Jansen, France) coated in 96 well plates were used instead of target cells to esterase activity on a 50-µl aliquot of cell-free supernatant was performed as previously described 7 .
Immunoprecipitation Flag-Rab27a WT or mutants and Mlph-Myc were co-expressed in 293T cells. One day after electroporation, cells were lysed in 50mM Tris pH 8.0, 1% Nonidet P-40, 2mM
EDTA, supplemented with 10µg/ml each of protease inhibitors leupeptin, aprotinin, N-tosyl-L-phenylalanine chloromethyl ketone, N-p-tosyl-L-lysine chloromethyl ketone and phenylmethylsulfonyl fluoride, as well as the phosphatase inhibitors 50mM sodium fluoride and 1mM sodium orthovanadate 27 . Anti-C-Myc (9E10, Santa Cruz Biotechnology, Hedelberg, Germany) and Anti Flag-M2 (Sigma) were used for immunoprecipitation.
Immune complexes were collected with Protein G (Sigma). Proteins were loaded in 12% SDS-polyacrylamide gel electrophoresis (PAGE) and transferred onto Immobilon membrane (Millipore,).
Results

Nucleotide binding and GTPase activity of Rab27a mutants-Three different homozygous
missense mutations of the Rab27a gene were found associated with Griscelli syndrome (L130P, A152P and W73G) pointing out to the biological relevance of these amino acid transitions. Based on the crystal structure of GTP-Rab3A 18 , L130P is located on the 5 sheet, A152P on the 4 loop and W73G on the 3 sheet near the nucleotide binding site (Fig.1) . To evaluate the molecular consequences of these substitutions, the Rab27a mutants were expressed and tested for their nucleotide binding ability as well as GTPase activity. In addition, the constitutively GTP-bound, active Rab27a Q78L mutant (equivalent to Rab3A Q81L in Fig.1 ), as well as the Rab27a T23N mutant (corresponding to Rab3A T36N in Fig.1) which is predominantly in the GDP-bound, inactive conformation, were also constructed and tested. As expected, WT Rab27a and Q78L mutant bind to GTP (Fig.2a) . Mutant W73G was shown to exhibit a similar GTP binding ability, although with lower kinetics. These three proteins also bind to GDP as does the T23N mutant (Fig. 2b) . In contrast, L130P and A152P mutants, were found to bind neither to GTP nor GDP nucleotides (Fig.2a,b) . The introduction of a proline at the mutation sites, most probably impairs the folding of these proteins as suggested by the specific detergent conditions required for their purification. Since both GTP and GDP binding activity were maintained when WT was prepared in the same conditions (data not shown), defective binding activity appears strictly related to the presence of the
and not to the experimental procedure used.
Fig.1 : Localization of Rab27a mutations on Rab3A structure
Ribbon representation of the Rab3A/GTP-bound structure with the putative switch regions highlighted in purple (switch1) and yellow (switch2) and the CDRs in blue. The amino acids mutated in Rab27a (-) patients (L130P, A152P and W73G), are indicated with an arrow at their equivalent position on the Rab3A structure, L132 and A154 (in brown) and W76 (in red), respectively. The constitutively active (Q78L) and inactive (T23N) Rab27a mutations are shown in green at their corresponding Rab3A residues, Q81 and T36, respectively. F59, Y91 in pink and W76 in red define the invariant hydrophobic triad.
The GTPase activity of the Rab27a proteins was next evaluated. Only the WT form of Rab27a
had an intrinsic GTP hydrolysis activity, whereas W73G as well as Q78L were inefficient in hydrolyzing GTP (Fig. 2c) . By analogy to other G proteins, the conserved Gln-78 residue is expected to stabilize the catalytic transition state between switch I and II. Transition to leucine, may lower this catalytic rate and lock the Rab protein into the activated, GTP-bound state. Residue 73 (residue 76 of Rab3A in Fig.1 ) is located in the 3 sheet, at the interface between the two switch regions. Similarly, its mutation alters GTPase activity possibly by modifying the conformational change of the P-Loop or the switch regions. We hypothesized
that a W to G transition may have increased switch flexibility and thus impaired the dynamics of the conformational changes associated with each nucleotide binding. To test this hypothesis, two other mutations at position 73 were generated, either a leucine residue (W73L), as in the p21 Ras protein, or a serine residue (W73S), which is supposed to limit switch II conformational liability possibly introduced by the Glycine residue. Although these mutants could bind GTP and GDP with high affinity (Fig. 2d and data not shown) , GTPase activity was not restored in either of these mutants (Fig. 2e) . This result strongly suggests that the conservation of a W at position 73 is essential for the intrinsic GTP hydrolysis activity of the Rab27a protein, independently of nucleotide binding.
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Fig.2 : Nucleotide binding rates and GTPase activities of Rab27a and the various mutants
Nucleotide binding and GTPase activity rates were measured by the filtration method and the data expressed as the percentage of the maximum radioactive nucleotide binding to Rab27a WT or mutant proteins. a-GTP binding ; The Rab27a (WT) and mutant (T23N, W73G, L130P, A152P) proteins were incubated with ( 3 H)-GTP for the indicated times, and the amount of bound ( 3 H)-GTP was determined. b-GDP binding ; Fixation of ( 3 H)-GDP with the same recombinant proteins. c-GTPase activities of proteins WT, W73G, Q78L ; The WT and mutant Rab27a proteins were loaded with ( -32 P)GTP, and GDP hydrolysis was determined by the release of 
Mutations at the W73-residue of Rab27a, a component of the invariant hydrophobic triad, impair effector binding
Most interesting was the observation, that the spontaneous mutant W73G observed in two patients with Griscelli syndrome, precisely affects one residue of the invariant hydrophobic triad suspected to impose critical conformational constraints to the active form of Rab protein, increasing effector binding specificity. We have thus evaluated the ability of this mutant to interact with one of its recently described effector, melanophilin. The specific interaction of the SHD domain of Mlph, with wild type Rab27a or its mutants, was investigated in vivo, using a Myc-tagged SHD domain of Mlph (Myc-SHD) and FLAG-tagged Rabs, which were co-expressed in 293T cells. As expected, Myc-SHD protein was specifically found coimmunoprecipited with the FLAG-Rab27a protein either in its wild type form or Q78L form, whereas the inactive GDP bound form T23N was not (Fig. 3a) . Although the W73G mutant of Rab27a exhibits both the same GTP binding activity and intrinsic GTPase deficiency as the constitutive active form Q78L, the association of W73G construct with Myc-SHD could not be detected (Fig.3b) . Similarly, two other mutants at position 73 (W73L and W73S), shown to efficiently bind GTP (Fig.1d) , were unable to associate with the SHD domain of Mlph ( 
Overexpression of Rab27a W73 mutants does not modify melanosome distribution
To address the function of the W73 Rab27a mutants, effect of their overexpression on melanosome distribution in melanocytes was analyzed. Transient overexpression of W73G in melan-a, a wild type mouse melanocyte cell line, did not significantly affect the localization of the pigment granules, which were evenly distributed throughout the cytoplasm (Fig 4C-D) , as observed in control EGFP-transfected cells (Fig 4A-B) . Similarly, W73L and W73S overexpression as well as T23N mutant overexpression in melan-a did not significantly modify melanososome distribution (not shown). In contrast, overexpression of the constitutively active Q78L Rab27a mutant, resulted in dramatic redistribution of pigment granules, which, in more than 50% of the transfected cells, were clustered in the perinuclear region (Fig.4 E-F) . A dominant negative effect was also mediated by the overexpression in this cell line, of the SHD domain of the Mlph able to interact with Rab27a ( Fig.4G-H Intracellular localization analysis of the transfected constructs fused with EGFP showed that the mutants constructs were mostly detected in the cytosol rather than associated with the membrane fraction (not shown). Together, these results suggest that in these cells, because of the inability of W73 mutants as well as T23N mutant to bind to endogenous Rab27a effector(s), these mutants do not interfere further with the endogenous Rab27a function. In contrast, the redistribution of melanosomes observed in Rab27a Q78L transfected cells, may result from the rerouting and stable binding of the total pool of endogenous Rab27a effector(s) by this active mutant highly expressed in the cytosol. In this situation, the endogenous Rab27a protein is likely deprived of its effector(s) association, essential for the For personal use only. on August 31, 2017. by guest www.bloodjournal.org From capture and peripheral movement of melanosomes. However, a dominant negative effect of Rab27a Q78L mutants has not been observed in previously reported studies 28, 29 . To better analyze the mechanism of the dominant negative effect observed with the Q78L mutant construct in our study, we investigated whether a normal phenotype could be rescued in melan-a cells co-transfected with both, the SHD domain of Mlph and the Rab27a Q78L mutant. The normal distribution of melanosomes observed in this situation (Fig.4I-J ) strongly supports our hypothesis of a dominant negative effect of Q78L through endogenous effector capture. In addition, the absence of W73 mutants' effect in the same situation, indirectly demonstrates in vivo the requirement of the W73 residue of Rab27a in specific melanophilineffector binding.
For 
Overexpression of Q78L, but not of W73G inhibits cytotoxic granule exocytosis
We have previously shown that Rab27a mutations in patients with Griscelli syndrome affect cytotoxic granule exocytosis, a finding further confirmed in the ashen murine model 10,11 .
Granule exocytosis was measured by analyzing the release into the supernatant, of the (BLT)-esterase (granzyme A) activity following lymphocyte TCR triggering, comparatively to the total BLT-esterase activity contained in the lymphocyte granules 7 . Granule exocytosis from patients' lymphocytes with W73G transition was found undetectable, whereas in the same conditions, 50% of the granule content of control lymphocytes was released (Fig.5a) . A dominant effect associated with overexpression of the Rab27a mutants was similarly assessed on granule content release from a H. saimiri-transformed cytotoxic CD8+ T cell line.
Transient overexpression of EGFP/Rab27a-W73G construct, did not significantly modify enzyme release when compared with wild type construct effect (Fig.5b) . In contrast, overexpression of the constitutive active mutant Q78L resulted in a significant inhibition of cytotoxic granule exocytosis (Fig.5b) . Thus, as observed in melanocytes overexpressing mutant constructs, Q78L but not W73G, interfere with the endogenous Rab27a intracellular pathway in lymphocytes. These results strongly suggest that in both cell types, Rab27a specific effectors binding require a spatial conformation of the triad, which is affected when W73 is mutated. 
Discussion
We herein report the molecular and functional analysis of three missense mutations in the Rab27a gene previously identified to result in the expression of Griscelli syndrome Rab27a. Similarly to the Q78L mutation, the W73G spontaneous mutant displays a constitutive active profile in terms of in vitro nucleotide-associated characteristics. However, these two mutants dramatically differ in their ability to interact with the SHD domain of the melanophilin, a recently identified effector of Rab27a 13, [15] [16] [17] . The W73G mutant was found unable to associate with its specific effector, while the Q78L mutant displayed a high affinity for it, demonstrating that W73 residue has a major role in effector binding. Lack of GTPase activity of W73G/W73L and W73S argue against a "native" conformation of the switch regions when other residues replace W. The configuration state that allows hydrolysis is probably not well populated. This differs from Q78L in which defective hydrolysis is due to a lack of stabilization of a water molecule 30 . W73 is one of the three hydrophobic conserved residues at the switch interface, previously shown in Rab3A to participate to Rab3A-Rabphilin3A interaction. In the Rab3/rabphilin complex, the three Rab3A residues of the triad, i.e. F59, W76 and Y91, are involved in a few van der Waals interactions with an apolar side of the first long helix of rabphilin (residues R60 and A61 for F59; residue A 61 for W76
and residue I58 for Y91). Since Melanophilin and Rabphilin-3A are highly similar for their Rab binding domain (among the 25 residues involved in interactions with Rab3 in the crystal structure, 9 residues are identical and 6 are conservative changes), it is likely that the overall interface between each Rab-effector complexe is similar. This invariant hydrophobic triad is thought to increase effector recognition specificity through the spatial conformation adopted by these residues in the active conformation of the protein. Functional difference between these W73 and Q78 mutants characteristics was also evidenced by their distinct effect on melanosome relocalisation in melan-a cells, as well as in cytotoxic granule release. Q78L mutant only was able to exert a dominant negative effect, leading to perinuclear clustering of melanososomes in melanocytes, and inhibition of cytotoxic granule exocytosis in lymphocytes. This dominant negative effect resulted from the sequestration of an upstream activator, since it was inhibited by the co-expression of melanophilin in melanocytes. In accordance with this observation, all other mutants, including W73G, unable to co-immunoprecipitate with melanophilin, did not modify melanosome transport. It is worth noting that, a dominant negative effect of the inactive T23N mutant has been reported (in 13% 28 to 80% 29 of the melanocytes), whereas the active Q78L construct had no effect. The fact that in our study, mutants expression pattern was similar in both cell types, and either
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Although Mlph was shown to be expressed in melanocytes, its presence is undetectable in cytotoxic cells, and accordingly, mutation in Mlph, which characterized leaden mice, does not affect cytotoxic activity 16 . It was thus hypothesized that either, another member of the Mlph geographic and medical contexts is a difficult task, it is interesting to note that patients with either A152P or W73G missense mutations had a later onset of HS than patients with null mutation. This suggests a possible in vivo residual activity of these mutated Rab proteins. 
